abstract |
A novel compound represented by general formula (I), having a potent TXA2 receptor antagonism and a PGI2 receptor agonism, and being useful in the treatment and prevention of diseases in which TXA2 participates. In said formula, the meaning of each symbol is as defined in the specification. |